Advertisement

Annals of Surgical Oncology

, Volume 25, Issue 8, pp 2178–2183 | Cite as

Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience

  • Jin-soo Park
  • Kheng-Seong Ng
  • Robyn P. M. Saw
  • John F. Thompson
  • Christopher J. Young
Melanomas

Abstract

Background

Melanoma metastatic to the large bowel (colon, rectum, and anus) is rarely diagnosed, with more than 95% of large bowel metastases identified post-mortem. The incidence, natural history, and survival rates of patients with large bowel melanoma metastases are poorly documented in the literature.

Objective

This study aimed to identify the incidence, clinical characteristics, and survival of patients with large bowel melanoma metastases.

Methods

A review was undertaken of all patients with melanoma treated over a 50-year period (1964–2014) at a tertiary referral center. Cases selected for study were those diagnosed with melanoma metastases in the colon, rectum, and anus. Primary colorectal and anal melanomas were excluded. Data were retrieved relating to patient demographics, clinical features, and survival.

Results

Of 38,279 patients with primary melanoma, 106 patients (0.3%, mean age 51.0 years [standard deviation 16.3], 64 males) developed large bowel metastases. The median interval between diagnosis of primary melanoma and large bowel metastasis was 62.8 months (range 1–476). The most common symptom was rectal bleeding (29.2%), and the large bowel was the sole site of metastasis in 47.2% of patients. Median survival from diagnosis of large bowel metastasis was 31.7 months (range 1–315), and overall survival at 1, 2, and 5 years was 68.1, 45.9, and 26.5%, respectively.

Conclusion

Our study provides insights into melanoma metastatic to the colon, rectum, and anus, which had an incidence of 0.3%. There are potentially long intervals between diagnosis of primary melanoma and large bowel metastasis. The most common symptom was rectal bleeding, although some patients were asymptomatic.

Notes

Author Contributions

Dr. Jin-soo Park is the primary author of this manuscript and contributed to data collection and writing of the final manuscript; Dr. Kheng-Seong Ng contributed to reviewing the final manuscript; Associate Professor Robyn P.M. Saw contributed to data collection and reviewing the final manuscript; Professor John F. Thompson contributed to data collection and reviewing the final manuscript; and Professor Christopher J. Young was involved in project conception and contributed to data collection and reviewing the final manuscript.

Disclosures

Jin-soo Park, Kheng-Seong Ng, Robyn P.M. Saw, John F. Thompson, and Christopher J. Young declare no conflicts of interest and no support from any organization for the submitted work. Robyn P.M. Saw has received honoraria from Bristol-Myers-Squibb, and John F. Thompson has received honoraria from Bristol-Myers Squibb, GlaxoSmithKline and Provectus, Inc., and is supported by the Melanoma Foundation of the University of Sydney. All authors agree with the content of the manuscript.

References

  1. 1.
    Australian Institute of Health and Welfare (AIHW). Australian cancer incidence and mortality (ACIM) books: melanoma of the skin. ACT: Canberra, 2017. http://www.aihw.gov.au/acim-books.
  2. 2.
    Tas F, Erturk K. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors. Melanoma Res. 2017;27(2):134–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Klaase JM, Kroon BBR. Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg. 1990;77(1):60–1.CrossRefPubMedGoogle Scholar
  4. 4.
    De la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res. 1983;43(7):3427–33.PubMedGoogle Scholar
  5. 5.
    Washington K, McDonagh D. Secondary tumors of the gastrointestinal tract: surgical pathologic findings and comparison with autopsy survey. Mod Pathol. 1995;8(4):427–33.PubMedGoogle Scholar
  6. 6.
    Reintgen DS, Thompson W, Garbutt J, Seigler HF. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery. 1984;95(6):635–9.PubMedGoogle Scholar
  7. 7.
    Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. Am J Surg. 1978;135(6):807–10.CrossRefPubMedGoogle Scholar
  8. 8.
    Tessier DJ, McConnell EJ, Young-Fadok T. Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum. 2003;46:441–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Agrawal S, Yao T-J, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999;6(4):336–44.CrossRefPubMedGoogle Scholar
  10. 10.
    Szynglarewicz B, Ekiert M, Forgacz J, Halon A, Skalik R, Matkowski R. The role of surgery in the treatment of colorectal metastases from primary skin melanoma. Colorectal Dis. 2012;14(6):e305–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Ihde JK, Coit DG. Melanoma metastatic to stomach, small bowel, or colon. Am J Surg. 1991;162(3):208–11.CrossRefPubMedGoogle Scholar
  12. 12.
    Faucheron JL, Mougin N, Trilling B. Malignant melanoma metastasis to the colon: a curable lesion. Tech Coloproctol. 2014;18(12):1189–90.CrossRefPubMedGoogle Scholar
  13. 13.
    McClenathan JH. Metastatic melanoma involving the colon. Dis Colon Rectum. 1989;32(1):70–2.CrossRefPubMedGoogle Scholar
  14. 14.
    Sanki A, Scolyer RA, Thompson JF. Surgery for melanoma metastases of the gastrointestinal tract: Indications and results. Eur J Surg Oncol. 2009;35(3):313–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Khadra MH, Thompson JF, Milton GW, McCarthy WH. The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract. Surg Gynecol Obstet. 1990;171(5):413–6.PubMedGoogle Scholar
  16. 16.
    Caputy GG, Donohue JH, Goellner JR, Weaver AL. Metastatic melanoma of the gastrointestinal tract. Results of surgical management. Arch Surg. 1991;126(11):1353–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;127:392Google Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Jin-soo Park
    • 1
  • Kheng-Seong Ng
    • 1
  • Robyn P. M. Saw
    • 2
    • 3
    • 4
  • John F. Thompson
    • 2
    • 3
    • 4
  • Christopher J. Young
    • 1
    • 4
    • 5
  1. 1.Department of Colorectal SurgeryRoyal Prince Alfred HospitalSydneyAustralia
  2. 2.Department of Melanoma and Surgical OncologyRoyal Prince Alfred HospitalSydneyAustralia
  3. 3.Melanoma Institute AustraliaThe University of SydneySydneyAustralia
  4. 4.Discipline of SurgeryThe University of SydneySydneyAustralia
  5. 5.RPAH Medical CentreNewtownAustralia

Personalised recommendations